Impact of long-term Xuezhikang therapy on cardiovascular events in high-risk patients with nonspecific, preexisting abnormal liver tests: A post-hoc analysis from Chinese Coronary Secondary Prevention Study (CCSPS)

Jian Jun Li; Zong Liang Lu; Wen Rong Kou; Roberto Bolli; Zuo Chen; Yang Feng Wu; Xue Hai Yu; Yu Cheng Zhao

doi:10.1016/j.ijcard.2011.11.005

Impact of long-term Xuezhikang therapy on cardiovascular events in high-risk patients with nonspecific, preexisting abnormal liver tests: A post-hoc analysis from Chinese Coronary Secondary Prevention Study (CCSPS)

Jian Jun Li, Zong Liang Lu, Wen Rong Kou, Roberto Bolli, Zuo Chen, Yang Feng Wu, Xue Hai Yu, Yu Cheng Zhao

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	362-365
Number of pages	4
Journal	International Journal of Cardiology
Volume	154
Issue number	3
DOIs	https://doi.org/10.1016/j.ijcard.2011.11.005
State	Published - Feb 9 2012
Externally published	Yes

Keywords

Abnormal liver test
Cardiovascular event
Myocardial infarction
Xuezhikang

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.ijcard.2011.11.005

Cite this

Li, J. J., Lu, Z. L., Kou, W. R., Bolli, R., Chen, Z., Wu, Y. F., Yu, X. H., & Zhao, Y. C. (2012). Impact of long-term Xuezhikang therapy on cardiovascular events in high-risk patients with nonspecific, preexisting abnormal liver tests: A post-hoc analysis from Chinese Coronary Secondary Prevention Study (CCSPS). International Journal of Cardiology, 154(3), 362-365. https://doi.org/10.1016/j.ijcard.2011.11.005

Impact of long-term Xuezhikang therapy on cardiovascular events in high-risk patients with nonspecific, preexisting abnormal liver tests: A post-hoc analysis from Chinese Coronary Secondary Prevention Study (CCSPS). / Li, Jian Jun; Lu, Zong Liang; Kou, Wen Rong et al.
In: International Journal of Cardiology, Vol. 154, No. 3, 09.02.2012, p. 362-365.

Research output: Contribution to journal › Article › peer-review

Li, JJ, Lu, ZL, Kou, WR, Bolli, R, Chen, Z, Wu, YF, Yu, XH & Zhao, YC 2012, 'Impact of long-term Xuezhikang therapy on cardiovascular events in high-risk patients with nonspecific, preexisting abnormal liver tests: A post-hoc analysis from Chinese Coronary Secondary Prevention Study (CCSPS)', International Journal of Cardiology, vol. 154, no. 3, pp. 362-365. https://doi.org/10.1016/j.ijcard.2011.11.005

@article{1ca63f58fd86444a95603b1af68b344b,

title = "Impact of long-term Xuezhikang therapy on cardiovascular events in high-risk patients with nonspecific, preexisting abnormal liver tests: A post-hoc analysis from Chinese Coronary Secondary Prevention Study (CCSPS)",

keywords = "Abnormal liver test, Cardiovascular event, Myocardial infarction, Xuezhikang",

author = "Li, {Jian Jun} and Lu, {Zong Liang} and Kou, {Wen Rong} and Roberto Bolli and Zuo Chen and Wu, {Yang Feng} and Yu, {Xue Hai} and Zhao, {Yu Cheng}",

year = "2012",

month = feb,

day = "9",

doi = "10.1016/j.ijcard.2011.11.005",

language = "English (US)",

volume = "154",

pages = "362--365",

journal = "International Journal of Cardiology",

issn = "0167-5273",

publisher = "Elsevier Ireland Ltd",

number = "3",

}

TY - JOUR

T1 - Impact of long-term Xuezhikang therapy on cardiovascular events in high-risk patients with nonspecific, preexisting abnormal liver tests

T2 - A post-hoc analysis from Chinese Coronary Secondary Prevention Study (CCSPS)

AU - Li, Jian Jun

AU - Lu, Zong Liang

AU - Kou, Wen Rong

AU - Bolli, Roberto

AU - Chen, Zuo

AU - Wu, Yang Feng

AU - Yu, Xue Hai

AU - Zhao, Yu Cheng

PY - 2012/2/9

Y1 - 2012/2/9

KW - Abnormal liver test

KW - Cardiovascular event

KW - Myocardial infarction

KW - Xuezhikang

UR - http://www.scopus.com/inward/record.url?scp=84855967741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855967741&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2011.11.005

DO - 10.1016/j.ijcard.2011.11.005

M3 - Article

C2 - 22133469

AN - SCOPUS:84855967741

SN - 0167-5273

VL - 154

SP - 362

EP - 365

JO - International Journal of Cardiology

JF - International Journal of Cardiology

IS - 3

ER -

Impact of long-term Xuezhikang therapy on cardiovascular events in high-risk patients with nonspecific, preexisting abnormal liver tests: A post-hoc analysis from Chinese Coronary Secondary Prevention Study (CCSPS)

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this